Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02091245
Title Phase I Trial of the Selective Inhibitor of Nuclear Export, KPT-330, in Relapsed Childhood ALL and AML
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Dana-Farber Cancer Institute
Indications

acute biphenotypic leukemia

acute lymphoblastic leukemia

acute myeloid leukemia

leukemia

chronic myeloid leukemia

Therapies

Selinexor

Age Groups: child
Covered Countries USA

Facility Status City State Zip Country Details
UCSF San Francisco California 94143 United States Details
Children's Hospital Colorado Aurora Colorado 80045 United States Details
Children's Healthcare of Atlanta Atlanta Georgia 30322 United States Details
Boston Children's Hospital Boston Massachusetts 02115 United States Details
Dana-Farber Cancer Institute Boston Massachusetts 02215 United States Details
Columbia University Medical Center New York New York 10032 United States Details
Children's Hospital of Philadelphia Philadelphia Pennsylvania 19104 United States Details
Texas Children's Hospital Houston Texas 77030 United States Details
Seattle Children's Hospital Seattle Washington 98101 United States Details
Children's Hospital of Wisconsin Milwaukee Wisconsin 53226 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field